Links among growth factors, hormones and nuclear factors with essential roles in bone formation

Critical Reviews in Oral Biology and Medicine

Volumn 11, Issue 4, 2000, Pages 409-422

  McCarthy, T L ^a   Ji, C ^a   Centrella, M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; Growth factors; Hormones; Nuclear transcription factors

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CORE BINDING FACTOR A1; GLUCOCORTICOID; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HORMONE; NUCLEAR FACTOR; NUCLEAR PROTEIN; PARATHYROID HORMONE; PROSTAGLANDIN E2; SEX HORMONE; SOMATOMEDIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; BONE REMODELING; CELL FUNCTION; CELL LINEAGE; HORMONE PROTEIN COMPLEX; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; STEM CELL;

EID: 0034529292     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411000110040201     Document Type: Review

References (122)

1. A model for development and evolution of complex morphological structures
2. Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell-cell interactions in osteoblast differentiation
3. PEBP2alphaB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials
4. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene
5. Runt homology domain proteins in osteoblast differentiation: AML3/CBFa1 is a major component of a bone-specific complex
6. Steroid receptors at the nexus of transcriptional regulation
7. The prevention or treatment of age-related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF-1 or rhTGF beta): A perspective
8. Expression of bone morphogenetic proteins in fracture healing
9. Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb
10. An estrogen receptor basis for raloxifene action in bone
11. Fibroblast growth factor receptors: Lessons from the genes
12. Role of platelet derived growth factor in bone cell function
13. Interleukin-6-specific activation of the C/EBP δ gene in hepatocytes is mediated by Stat3 and Spl
14. Transforming and non-transforming growth factors are present in culture medium conditioned by fetal rat calvariae
15. Human platelet-derived transforming growth factor beta stimulates parameters of bone growth in fetal rat calvariae
16. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat calvariae
17. Glucocorticoid regulation of transforming growth factor β1 (TGF-β1) activity and binding in osteoblast-enriched cultures from fetal rat bone
18. Growth factors and cytokines
19. Isoform specific regulation of platelet-derived growth factor activity and binding in osteoblast-enriched cultures from fetal rat bone
20. Transforming growth factor-β gene family members, their receptors, and bone cell function
21. Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein-2 parallel expression of the osteoblast phenotype
22. The role of prostaglandins and nitric oxide in the response of bone to mechanical stimulation
23. Reduction in transforming growth factor β receptor 1 and transcription factor CBFa1 on bone cells by glucocorticoid
24. Role of nitric oxide and prostaglandins in mechanically induced bone formation
25. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-1 serum levels in women with breast cancer
26. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence
27. Effects of tamoxifen on GH and IGF-1 levels in acromegaly
28. C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver
29. The role of C/EBP genes in adipocyte differentiation
30. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcription activator protein
31. Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth
32. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
33. Transforming growth factor-beta 1: Induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with osteogenic protein-1 (BMP-7)
34. Haploinsufficient phenotypes in BMP4 heterozygous null mice and modifications by Gli3 and Alx4
35. AUK Consensus Group on management of glucocorticoid-induced osteoporosis: An update
36. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: Evidence for transcriptional control
37. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
38. Functional cooperation between the non-paralogous genes Hoxa-10 and Hoxd-11 in the deveioping forelimb and axial skeleton
39. The biology of the cytokine sequence cascade
40. Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in forelimb and axial skeletal patterning
41. Involvement of CCAAT/enhancer-binding protein and nuclear factorκB binding sites in interleukin-6 promoter inhibition by estrogens
42. A PEBP2 /AML1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element
43. Transcriptional cross-talk, the second mode of steroid hormone receptor action
44. The potential role of chemokines and inflammatory cytokines in periodontal disease progression
45. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist
46. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
47. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome
48. A phase 1/11 clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease
49. Cytokine networks in destructive periodontal disease
50. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosoreal dominant craniosynostosis
51. The in vivo anabolic actions of prostaglandins in bone
52. Cloning, characterization and expression of the transforming growth factor-β type I receptor promoter in fetal rat bone cells
53. Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-β type I receptor
54. CBF (AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation
55. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3
56. Potential mechanism of estrogen-mediated decrease in bone formation: Estrogen increases production of inhibitory insulin-like growth factor-binding protein-4
57. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
58. Pro-inflammatory cytokines downregulate platelet derived growth factor-alpha receptor gene expression in human osteoblastic cells
59. Modulation of the effects of glucocorticoids on collagen synthesis in fetal rat calvariae by insulin-like growth factor binding protein-2
60. The science and therapy of glucocorticoid-induced bone loss
61. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
62. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization
63. Defective bone formation in Krox-20 mutant mice
64. Prostaglandin E2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats
65. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation
66. Interleukin-1 in combination with transforming growth factor-alpha produces enhanced bone resorption in vitro
67. Role of cytokines in bone resorption
68. Effects of transforming growth factor β and interleukin 1α on prostaglandin synthesis in serum-deprived osteoblastic cells
69. The paired-like homeobox gene MHox is required for early events of skeletogenesis in multiple lineages
70. TGF-beta signal transduction
71. Regulation of IGF activity in bone
72. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone
73. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells
74. Cortisol inhibits the synthesis of insulin-like growth factor 1 in bone cell cultures
75. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures
76. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone
77. Regulation of insulin-like growth factor I transcription I by cyclic AMP in fetal rat bone cells through an element within exon 1: Protein kinase A dependent control without a consensus cyclic AMP response element
78. 17β-estradiol potently suppresses cAMP induced insulin-like growth factor-I (IGF-I) gene activation in primary rat osteoblast cultures
79. Time- and close-related interactions between glucocorticoid and cAMP on C/EBP-dependent IGF-I expression by osteoblasts
80. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
81. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/runt domain transcription factor family: Interactions with the osteocalcin gene promoter
82. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation
83. Parathyroid hormone and parathyroid hormone-related protein: Model systems for the development of an osteoporosis therapy
84. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia
85. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development
86. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
87. CREB controls LAP/C/EBP β transcription
88. C/EBP, c-Myb, and PU. 1 cooperate to regulate the neutrophil elastase promoter
89. Molecular cloning and characterization of PEBP2beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2
90. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene
91. Cbfa I, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
92. The role of C/EBP isoforms in the control of inflammatory and native immunity function
93. Local and systemic factors in the pathogenesis of osteoporosis
94. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism
95. Bone and cytokines: Beyond IL-1, IL-6 and TNF-alpha
96. Role of osteoblasts in hormonal control of bone resorption-a hypothesis
97. Estrogen modulates the mRNA levels for cancellous bone protein of ovariectomized rats
98. Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats
99. Tamoxifen and estrogen lower circulating lipoprotein (a) concentrations in healthy postmenopausal women
100. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton
101. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
102. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
103. Fibroblast growth factors as multifunctional signaling factors
104. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbf
105. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-1 gene by prostaglandin E2 in osteoblasts
106. Repair of nasal defects using collagen gels containing insulin-like growth factor 1
107. Mice, estrogen, and postmenopausal osteoporosis
108. Evidence that the inhibition of osteoblast activity by estrogen is preceded by down regulation of IGF-1 gene expression and that these changes are estrogen receptor mediated
109. Mechanism of action of estrogen on intramembranous bone formation: Regulation of osteoblast differentiation and activity
110. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: Inhibition of indices of formation and resorption
111. CCAAT/enhancer binding protein delta (C/EBPδ) activates insulin-like growth factor-1 gene transcription in osteoblasts: Identification of a novel cyclic AMP signaling pathway in bone
112. CCAAT/enhancer binding protein δ is a critical regulator of insulin-like growth factor-1 gene transcription in osteoblasts
113. The C/EBP family of transcription factors
114. A family of C/EBP related proteins capable of forming covalently linked leucine zipper dimers in vitro
115. Regulation of the growth hormone-insulin-like growth factor 1 axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor 1
116. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair
117. TGF-beta receptors and signalling mechanisms
118. CCAAT/enhancer-binding protein δ gene expression is mediated by APRF/STAT3
119. CCAAT/enhancer-binding protein δ gene expression is mediated by autoregulation through downstream binding sites
120. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
121. Growth factors and bone regeneration: Implications of barrier membranes
122. CCAAT enhancer binding protein (C/EBP) and AML-1 (CBFalpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter